Envoy Medical Inc.
(NASDAQ:COCH) on Tuesday said it surpassed the three-month milestone for all 56 patients enrolled in the company’s pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant.
Envoy Medical Completes Three-Month Milestone In Acclaim Trial The update marks another important clinical trial milestone as the company continues to build momentum with the hearing industry.
Read Also: EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear "Envoy Medical continues to demonstrate its ability to execute," said Brent Lucas, CEO of Envoy Medical.
"Each milestone achieved brings us one big step closer to our next major goal – submission of our PMA application to the FDA." FDA Submission Timeline Remains On Track The company is continuing to collect safety and other study measures as part of its ongoing pivotal trial, with full data to be included as part of its planned Premarket Approval (PMA) submission to the U.S.
